We are live on
!
Find out more
BCM
Beddow Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
18.36%
This Fund
S&P 500
This Quarter
Est. Return
+1.14%
1 Year Est. Return
+18.36%
3 Year Est. Return
+50.71%
5 Year Est. Return
+107.72%
10 Year Est. Return
+272.89%
AUM
$252M
AUM Growth
-$14.9M
(-5.6%)
Cap. Flow
-$13.3M
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
49.35%
Holding
57
New
–
Increased
11
Reduced
36
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$1.24M |
| 2 |
Mettler-Toledo International
MTD
|
+$808K |
| 3 |
Chord Energy
CHRD
|
+$683K |
| 4 |
Diamondback Energy
FANG
|
+$204K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$130K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Pacific Land
TPL
|
+$1.54M |
| 2 |
Pfizer
PFE
|
+$1.52M |
| 3 |
IBM
IBM
|
+$1.22M |
| 4 |
Bladex Inc
BLX
|
+$1.1M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$762K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 21.59% |
| 2 | Technology | 11.25% |
| 3 | Financials | 10.96% |
| 4 | Materials | 10.56% |
| 5 | Healthcare | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Texas Pacific Land
TPL
$28.9B
| $23.7M | 9.4% |
67,353
-3,756
| -5% | -$1.54M |
|
|
2
IBM
IBM
$202B
| $14.8M | 5.88% |
50,328
-4,730
| -9% | -$1.22M |
|
|
3
Bladex Inc
BLX
$2.24B
| $13.9M | 5.53% |
346,026
-27,735
| -7% | -$1.1M |
|
4
Dollar General
DG
$25.9B
| $12.3M | 4.86% |
107,190
-4,460
| -4% | -$443K |
|
5
Autoliv
ALV
$8.6B
| $10.3M | 4.08% |
91,970
-3,685
| -4% | -$361K |
|
|
SI
6
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $9.59M | 3.8% |
74,450
-4,740
| -6% | -$611K |
|
|
MSB
7
Mesabi Trust
MSB
$295M
| $8.99M | 3.56% |
375,095
-27,980
| -7% | -$727K |
|
8
Franco-Nevada
FNV
$41.4B
| $8.79M | 3.48% |
53,617
-2,990
| -5% | -$495K |
|
9
Wheaton Precious Metals
WPM
$50.6B
| $8.59M | 3.4% |
95,668
-6,925
| -7% | -$583K |
|
10
Citigroup Capital XIII 7.875% Fixed Rate/Floating Rate Trust Preferred Securities
C.PRN
$2.55B
| $8.52M | 3.37% |
289,505
-9,755
| -3% | -$288K |
|
|
11
Berkshire Hathaway Class B
BRK.B
$1.07T
| $8.15M | 3.23% |
16,776
+256
| +2% | +$130K |
|
|
ABB
12
DELISTED
ABB Ltd
ABB
| $7.76M | 3.07% |
129,975
-6,785
| -5% | -$405K |
|
13
Johnson & Johnson
JNJ
$635B
| $7.64M | 3.03% |
50,040
-2,425
| -5% | -$373K |
|
14
Cheniere Energy
LNG
$56.5B
| $7.55M | 2.99% |
31,015
-3,050
| -9% | -$706K |
|
15
AbbVie
ABBV
$458B
| $6M | 2.38% |
32,310
-2,080
| -6% | -$387K |
|
|
16
Organon & Co
OGN
$3.55B
| $5.89M | 2.33% |
608,075
+120,150
| +25% | +$1.24M |
|
|
17
Chord Energy
CHRD
$7.79B
| $5.24M | 2.08% |
54,110
+7,175
| +15% | +$683K |
|
|
18
Berkshire Hathaway Class A
BRK.A
$1.07T
| $5.1M | 2.02% |
7
-1
| -13% | -$762K |
|
19
Oracle
ORCL
$331B
| $4.87M | 1.93% |
22,275
-4,135
| -16% | -$668K |
|
|
CTRA
20
DELISTED
Coterra Energy
CTRA
| $4.87M | 1.93% |
191,794
-10,751
| -5% | -$273K |
|
21
EOG Resources
EOG
$78B
| $4.58M | 1.81% |
38,295
-1,350
| -3% | -$154K |
|
22
Shell
SHEL
$245B
| $4.17M | 1.65% |
59,226
-2,625
| -4% | -$176K |
|
|
23
Diamondback Energy
FANG
$57.6B
| $3.83M | 1.52% |
27,875
+1,470
| +6% | +$204K |
|
|
24
Mettler-Toledo International
MTD
$26.8B
| $2.5M | 0.99% |
2,128
+723
| +51% | +$808K |
|
|
25
Pfizer
PFE
$140B
| $2.35M | 0.93% |
97,045
-65,085
| -40% | -$1.52M |
|
Similar funds
MCP
FCIS
SCM
GFA
RA
OI
GFG
EFA
Beddow Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Beddow Capital Management held 57 positions worth $252M, down 5.6% from $267M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Beddow Capital Management withdrew a net $13.3M in Q2 2025, closing 2 positions and reducing 36 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $297K position sold in full.
By sector, the portfolio is most concentrated in Energy at 22% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
Against the trend, Beddow Capital Management added an estimated $1.24M to Organon & Co.
- Beddow Capital Management added most to Organon & Co in Q2 2025, an estimated $1.24M increase.
- Beddow Capital Management's biggest Q2 2025 reduction was Texas Pacific Land, cutting an estimated $1.54M.
- Beddow Capital Management fully exited Bristol-Myers Squibb in Q2 2025, selling an estimated $297K.
- Beddow Capital Management's ten largest holdings make up 49% of its $252M portfolio in Q2 2025.
- Beddow Capital Management opened 0 new positions and closed 2 in Q2 2025.
- Beddow Capital Management's portfolio value fell 5.6% quarter-over-quarter to $252M.
Based on Beddow Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.